Molecular detection and analysis firm Oxford Nanopore Technologies has raised £40m ($64m) in private equity funding from new and existing backers. Founded in 2005, the firm is commercialising a DNA sequencing system which utilises nanopores originally developed at the University of Oxford. Its technologies can be used in DNA sequencing, diagnostics, drug development, biomolecular interaction,…
Oxford Nanopore receives £40m
Oct 9, 2013 •
LEADERSHIP SOCIETYInforming, connecting, and transforming the global corporate venture capital ecosystem.
The Global Corporate Venturing (GCV) Leadership Society’s mission is to help bridge the different strengths and ambitions of investors across industry sectors, geography, structure, and their returns.
More featured content
Resistance is futile: seven superconductor companies that want to change the world
From healthcare to fusion to quantum computing to space, superconductors have the potential to revolutionise the world. And the technology is finally ready to commercialise.
UK universities urged to lower spinout stakes
A new report recommends stakes of less than 25% but fails to address the issue of access to early-stage capital.
Feb 7, 2024
Mar 14, 2024
Monterey, CA (USA)
Jun 26, 2024